<VariationArchive VariationID="817839" VariationName="NM_013382.7(POMT2):c.1712dup (p.Ile572fs)" VariationType="Duplication" Accession="VCV000817839" Version="6" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-05-19" DateCreated="2020-03-16" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="805803" VariationID="817839">
      <GeneList>
        <Gene Symbol="POMT2" FullName="protein O-mannosyltransferase 2" GeneID="29954" HGNC_ID="HGNC:19743" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="77274956" stop="77320883" display_start="77274956" display_stop="77320883" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="77741298" stop="77787224" display_start="77741298" display_stop="77787224" Strand="-" />
          </Location>
          <OMIM>607439</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_013382.7(POMT2):c.1712dup (p.Ile572fs)</Name>
      <CanonicalSPDI>NC_000014.9:77280404:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>14q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="77280404" stop="77280405" display_start="77280404" display_stop="77280405" variantLength="1" positionVCF="77280404" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="77746747" stop="77746748" display_start="77746747" display_stop="77746748" variantLength="1" positionVCF="77746747" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>I572fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.77746749dup" Assembly="GRCh37">
            <Expression>NC_000014.8:g.77746749dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.77280406dup" Assembly="GRCh38">
            <Expression>NC_000014.9:g.77280406dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008897.1" sequenceAccession="NG_008897" sequenceVersion="1" change="g.45478dup">
            <Expression>NG_008897.1:g.45478dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013382.7" sequenceAccession="NM_013382" sequenceVersion="7" change="c.1712dup" MANESelect="true">
            <Expression>NM_013382.7:c.1712dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_037514.2" sequenceAccession="NP_037514" sequenceVersion="2" change="p.Ile572fs">
            <Expression>NP_037514.2:p.Ile572fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_844" sequenceAccession="LRG_844">
            <Expression>LRG_844:g.45478dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_844t1" sequenceAccession="LRG_844t1">
            <Expression>LRG_844t1:c.1712dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="780725241" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_013382.7(POMT2):c.1712dup (p.Ile572fs) AND not provided" Accession="RCV001009061" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-09-26" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_013382.7(POMT2):c.1712dup (p.Ile572fs) AND multiple conditions" Accession="RCV003769416" Version="1">
        <ClassifiedConditionList TraitSetID="9652">
          <ClassifiedCondition DB="MedGen" ID="C3150418">Autosomal recessive limb-girdle muscular dystrophy type 2N</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3150411">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3150416">Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_013382.7(POMT2):c.1712dup (p.Ile572fs) AND Inborn genetic diseases" Accession="RCV002551722" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_013382.7(POMT2):c.1712dup (p.Ile572fs) AND POMT2-related disorder" Accession="RCV003411949" Version="4">
        <ClassifiedConditionList TraitSetID="89718">
          <ClassifiedCondition>POMT2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-18" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_013382.7(POMT2):c.1712dup (p.Ile572fs) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2" Accession="RCV003473558" Version="1">
        <ClassifiedConditionList TraitSetID="825">
          <ClassifiedCondition DB="MedGen" ID="C3150411">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-02" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2020-03-16" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15894594</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89718" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="71359" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">POMT2-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">POMT2-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="825" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9863" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2</ElementValue>
                <XRef ID="Congenital+muscular+dystrophy-dystroglycanopathy+with+brain+and+eye+anomalies%2C+type+A2/8070" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED</ElementValue>
                <XRef Type="MIM" ID="613150" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2</ElementValue>
                <XRef Type="MIM" ID="613150" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2</ElementValue>
                <XRef ID="MONDO:0013154" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MDDGA2</ElementValue>
                <XRef Type="MIM" ID="613150" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">POMT2-Related Muscle Diseases</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15624" />
                <XRef ID="15624" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C3150411" DB="MedGen" />
              <XRef ID="MONDO:0013154" DB="MONDO" />
              <XRef Type="MIM" ID="613150" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9652" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9863" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2</ElementValue>
                <XRef ID="Congenital+muscular+dystrophy-dystroglycanopathy+with+brain+and+eye+anomalies%2C+type+A2/8070" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED</ElementValue>
                <XRef Type="MIM" ID="613150" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2</ElementValue>
                <XRef Type="MIM" ID="613150" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2</ElementValue>
                <XRef ID="MONDO:0013154" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MDDGA2</ElementValue>
                <XRef Type="MIM" ID="613150" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">POMT2-Related Muscle Diseases</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15624" />
                <XRef ID="15624" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C3150411" DB="MedGen" />
              <XRef ID="MONDO:0013154" DB="MONDO" />
              <XRef Type="MIM" ID="613150" DB="OMIM" />
            </Trait>
            <Trait ID="9864" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2</ElementValue>
                <XRef ID="MONDO:0013160" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2</ElementValue>
                <XRef Type="MIM" ID="613156" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607439.0017" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, CONGENITAL, POMT2-RELATED</ElementValue>
                <XRef Type="MIM" ID="613156" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDDGB2</ElementValue>
                <XRef Type="MIM" ID="613156" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">POMT2-Related Muscle Diseases</Attribute>
              </AttributeSet>
              <XRef ID="C3150416" DB="MedGen" />
              <XRef ID="MONDO:0013160" DB="MONDO" />
              <XRef Type="MIM" ID="613156" DB="OMIM" />
            </Trait>
            <Trait ID="9865" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2N</ElementValue>
                <XRef ID="MONDO:0013162" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy-dystroglycanopathy, type C2</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C2/8751" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMT2-RELATED</ElementValue>
                <XRef Type="MIM" ID="613158" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LGMD2N</ElementValue>
                <XRef Type="MIM" ID="613158" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MDDGC2</ElementValue>
                <XRef Type="MIM" ID="613158" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">POMT2-Related Muscle Diseases</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12539" />
                <XRef ID="12539" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="206559" DB="Orphanet" />
              <XRef ID="C3150418" DB="MedGen" />
              <XRef ID="MONDO:0013162" DB="MONDO" />
              <XRef Type="MIM" ID="613158" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2306864" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:2432750|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001168871" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.1712dupC variant in the POMT2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The 1712dupC variant causes a frameshift starting with codon Isoleucine 572, changes this amino acid to a Tyrosine residue, and creates a premature Stop codon at position 13 of the new reading frame, denoted p.Ile572TyrfsX13. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The 1712dupC variant is observed in 1/246254 (0.0004%) alleles in large population cohorts (Lek et al., 2016). We interpret 1712dupC as a likely pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POMT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_013382.5:c.1712dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7684948" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="25468027|POMT2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004109133" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The POMT2 c.1712dupC variant is predicted to result in a frameshift and premature protein termination (p.Ile572Tyrfs*13). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in POMT2 are expected to be pathogenic. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POMT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_013382.5:c.1712dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">POMT2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7855968" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_013382.7:c.1712dup|OMIM:613150" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004204094" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_013382.7:c.1712dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613150" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8558818" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="3044811|MedGen:C3150416;C3150411;C3150418" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004604013" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15894594</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ile572Tyrfs*13) in the POMT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POMT2 are known to be pathogenic (PMID: 15894594). This variant is present in population databases (rs780725241, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with POMT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 817839). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POMT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.77746747_77746748insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3150416" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3150411" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3150418" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6251135" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="a9655248|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003556216" DateUpdated="2024-05-01" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1712dupC (p.I572Yfs*13) alteration, located in exon 16 (coding exon 16) of the POMT2 gene, consists of a duplication of C at position 1712, causing a translational frameshift with a predicted alternate stop codon after 13 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from the Genome Aggregation Database (gnomAD) database, the POMT2 c.1712dupC alteration was observed in &lt;0.01% (1/251468) of total alleles studied. Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POMT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_013382.5:c.1712dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6251135" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7855968" TraitType="Disease" MappingType="XRef" MappingValue="613150" MappingRef="OMIM">
        <MedGen CUI="C3150411" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8558818" TraitType="Disease" MappingType="XRef" MappingValue="C3150418" MappingRef="MedGen">
        <MedGen CUI="C3150418" Name="Autosomal recessive limb-girdle muscular dystrophy type 2N" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7684948" TraitType="Disease" MappingType="Name" MappingValue="POMT2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="POMT2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8558818" TraitType="Disease" MappingType="XRef" MappingValue="C3150411" MappingRef="MedGen">
        <MedGen CUI="C3150411" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2306864" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8558818" TraitType="Disease" MappingType="XRef" MappingValue="C3150416" MappingRef="MedGen">
        <MedGen CUI="C3150416" Name="Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

